Literature DB >> 22762854

Differences between patient medication records held by general practitioners and the drugs actually consumed by the patients.

Guido Schmiemann1, Marcel Bahr, Alla Gurjanov, Eva Hummers-Pradier.   

Abstract

OBJECTIVE: The pattern of drugs actually consumed by patients can differ from that shown in the medical records held by the general practitioners. Reasons for such differences, in patients receiving polypharmacy, were analyzed in this study.
MATERIALS AND METHODS: Medication records provided by general practitioners (GP) were compared with the pattern of drugs actively taken by their patients. Reasons to explain why drugs taken by patients were missing from their physician`s records were analyzed on the basis of information obtained from interviews with GPs.
RESULTS: Discrepancies involved 170 drugs in 87 patients and > 90% of the discrepancies could be attributed to four causes. These were: 1. Organizational aspects 2. Lack of documentation 3. A drug prescribed by a specialist without informing the GP, and 4. Patients' use of over the-counter medication (OTCs). Drugs most affected were magnesium and acetylsalicylic acid.
CONCLUSION: Omissions in medication records held by GPs are mostly due to organizational deficiencies in information transfer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22762854     DOI: 10.5414/CP201682

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  8 in total

1.  Design and analytic considerations for using patient-reported health data in pragmatic clinical trials: report from an NIH Collaboratory roundtable.

Authors:  Frank W Rockhold; Jessica D Tenenbaum; Rachel Richesson; Keith A Marsolo; Emily C O'Brien
Journal:  J Am Med Inform Assoc       Date:  2020-04-01       Impact factor: 4.497

Review 2.  Polypharmacy-an Upward Trend with Unpredictable Effects.

Authors:  Dirk Moßhammer; Hannah Haumann; Klaus Mörike; Stefanie Joos
Journal:  Dtsch Arztebl Int       Date:  2016-09-23       Impact factor: 5.594

3.  High Prevalence of Medication Discrepancies Between Home Health Referrals and Centers for Medicare and Medicaid Services Home Health Certification and Plan of Care and Their Potential to Affect Safety of Vulnerable Elderly Adults.

Authors:  Abraham A Brody; Bryan Gibson; David Tresner-Kirsch; Heidi Kramer; Iona Thraen; Matthew E Coarr; Randall Rupper
Journal:  J Am Geriatr Soc       Date:  2016-09-27       Impact factor: 5.562

Review 4.  Design and delivery of a tailored intervention to implement recommendations for multimorbid patients receiving polypharmacy into primary care practices.

Authors:  Cornelia Jäger; Joachim Szecsenyi; Jost Steinhäuser
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

5.  A tailored implementation intervention to implement recommendations addressing polypharmacy in multimorbid patients: study protocol of a cluster randomized controlled trial.

Authors:  Cornelia Jäger; Tobias Freund; Jost Steinhäuser; Stefanie Joos; Michel Wensing; Joachim Szecsenyi
Journal:  Trials       Date:  2013-12-05       Impact factor: 2.279

6.  Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot).

Authors:  Christiane Muth; Sebastian Harder; Lorenz Uhlmann; Justine Rochon; Birgit Fullerton; Corina Güthlin; Antje Erler; Martin Beyer; Marjan van den Akker; Rafael Perera; André Knottnerus; Jose M Valderas; Ferdinand M Gerlach; Walter E Haefeli
Journal:  BMJ Open       Date:  2016-07-25       Impact factor: 2.692

7.  Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population.

Authors:  Mercedes Gimeno-Gracia; María José Crusells-Canales; Francisco Javier Armesto-Gómez; Vicente Compaired-Turlán; María José Rabanaque-Hernández
Journal:  Clin Interv Aging       Date:  2016-08-26       Impact factor: 4.458

8.  Benefits of medication charts provided at transitions of care: a narrative systematic review.

Authors:  Fine Michèle Dietrich; Kurt E Hersberger; Isabelle Arnet
Journal:  BMJ Open       Date:  2020-10-22       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.